Articles tagged "Survival"

2018 American Transplant Congress
Cumulative United States Experience in Domino Liver Transplants
K. Barrera, S. Sharma, A. Gruessner, R. Gruessner.
Surgery, State University of New York, Downstate, Brooklyn, CA.
Background/Purpose: The ongoing shortage of livers in the setting of growing waiting lists remains a challenge in transplantation. First introduced in 1995, sequential or domino…
2018 American Transplant Congress
Kidney Graft Outcomes in Combined Heart-Kidney Transplantation: A UNOS Database Analysis 2000-2015
A. Riaz, O. Adebiyi, D. Mishler, M. Yaqub, T. Taber, A. Sharfuddin.
Indiana University, Indianapolis.
Background: Combined Heart-Kidney Transplantation (CHKT) is the optimal therapy for patients with advanced renal dysfunction. Our aim was to analyze kidney specific graft outcomes in…
2018 American Transplant Congress
Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis
K. Yoon, K. Lee, S. Hong, J-.H. Cho, J-.M. Lee, N-.J. Yi, K. Suh.
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Introduction: Liver transplantation(LT) has better outcomes even in patient with child A than LR because LT can overcome the tumor and background liver factors. We…
2018 American Transplant Congress
Impact of Providing Care Locally Compared to at a Transplant Center for Pre-And Posttransplant Liver Patients
R. Shahbazov,¹ K. Knapp,² S. Tsutsui,² A. Nickkholgh,¹ P. Northup,³ J. Oberholzer,¹ D. Maluf,¹ M. Shiffman,⁴ S. Pelletier.¹
¹Surgery, University of Virginia Healthsystem, Charlottesville, VA; ²University of Virginia School of Medicine, University of Virginia Healthsystem, Charlottesville, VA; ³Gastroenterology, University of Virginia Healthsystem, Charlottesville, VA; ⁴Secours Liver Institute of Richmond, Secours Liver Institute of Richmond, Richmond, VA.
There is a potential to improve patient satisfaction as well as access to liver transplantation (LT). AIM: This study evaluated outcomes of LT recipients whose…
2018 American Transplant Congress
Impact of Preserved Collateral Veins on Small-for-Size Grafts in Living Donor Liver Transplantation
B-.G. Na, E. Lee, S. Kim, S. Park.
Center for Liver Cancer, National Cancer Center Research Institute, Goyang, Republic of Korea.
Purpose: Graft size is a critical issue in living donor liver transplantation (LDLT). We hypothesized that too much portal flow could possibly be diverted into…
2018 American Transplant Congress
Impact of Antecedent Malignancy on Kidney Transplant Outcomes: Patient, Graft, and Cancer-Free Survival
O. Serrano,¹ S. Mongin,² D. Berglund,¹ D. Vock,³ S. Chinnakotla,¹ T. Dunn,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas.¹
¹Surgery, University of Minnesota, Minneapolis, MN; ²Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, Minneapolis, MN; ³Biostatistics, University of Minnesota, Minneapolis, MN.
OBJECTIVE: Non-skin pretransplant malignancy (NSPTM) has historically been considered a relative contraindication to kidney transplantation (KT). In addition to the conventional risk factors for cancer,…
2018 American Transplant Congress
A Low Level of De Novo DSA Sialylation is Associated with a Decreased of Allograft Survival in Non-Sensitized Kidney Transplant Recipients
M. Bonnet,^1,2 V. Pernin,^1,3 J-.E. Serre,¹ V. Georgescu,⁴ M. Le Quintrec,^1,2,3 G. Mourad,^1,2 J-.F. Eliaou,^2,5 C. Rene.^2,5
¹Nephrology, Dialysis and Transplantation, Hôpital Lapeyronie, Montpellier University Hospital, Montpellier, France; ²University of Medicine, Montpellier University, Montpellier, France; ³Inserm U1183, IRMB, Hôpital Saint Eloi, Montpellier University Hospital, Montpellier, France; ⁴Department of Medical Information, Montpellier University Hospital, Montpellier, France; ⁵Department of Immunology, Hôpital Saint Eloi, Montpellier University Hospital, Montpellier, France.
Background. In kidney transplantation, de novo donor specific antibodies (dnDSA) are associated with antibody-mediated rejection (ABMR) and graft failure. While appearance of dnDSA, there is…
2018 American Transplant Congress
MELD Based Allocation Deteriorates Patient Survival without Improving Waiting List Mortality in a Low Donor Area
P. Ritschl, L. Wiering, F. Aigner, M. Biebl, D. Eurich, M. Schmelzle, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.
Department of Surgery, Campus Charité Mitte / Campus Virchow-Klinikum CCM/CVK, Charité - Universitätsmedizin Berlin, Berlin, Germany.
The MELD-based allocation system has been implemented in Germany in 2006 in order to decrease waiting list mortality in patients with end stage liver disease.…
2018 American Transplant Congress
Outcomes after Cardiac Transplantation for Adult Congenital Heart Disease in the Modern Era
X. Zeng,¹ R. Vela,² J. Pruszynski,² J. Martinez,² S. Ring,² M. Peltz.²
¹Surgery, University of Texas Southwestern Medical Center, Dallas, TX; ²Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallss, TX.
Background: More patients with congenital heart disease (CHD) are surviving into adulthood and require heart transplantation. These patients historically experienced worse survival early after transplantation.…
2018 American Transplant Congress
Outcomes from 194 Consecutive Split Left Liver Transplants: Comparison of Living versus Deceased Donors
D. Adamson, P. Tabrizian, M. Parides, K. Iyer, J. Moon, J. Chu, R. Arnon, S. Florman.
Recanati/Miller Transplant Institute, Mount Sinai Hospital, New York.
Methods:Analysis of long term outcomes of 194 consecutive left lateral segment grafts (LLS) including 94 living (LD) and 99 deceased (DD) donor grafts (1992 -…